Trials / Completed
CompletedNCT02861963
Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients
Femoral Allogenic Vein Valved Conduit for Palliative Repair of Pulmonary Atresia With Ventricular Septal Defect
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 1 Day – 1 Year
- Healthy volunteers
- Not accepted
Summary
The aim is to compare effective growth true hypoplastic pulmonary arteries using Right Ventricle Outflow Tract Reconstruction by femoral allogenic vein valve conduit and systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)
Detailed description
The use of femoral allogenic vein valve conduit for Right Ventricle Outflow Tract Reconstruction is good alternative systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt). Main advantages is straight, symmetrical, pulsating, systolic blood flow in hypoplastic pulmonary artery, which stimulate growth and prepares for a radical repair. Taking into account the absence randomized studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Experimental: RVOT reconstruction by femoral allogenic vein valve conduit | Right ventricular outflow tract reconstruction using femoral allogenic vein valve conduit under CPB and induced ventricular fibrillation |
| PROCEDURE | Systemic-to-pulmonary artery shunts | Modified Blalock-Taussig shunt performed between the right subclavian and pulmonary arteries or the left subclavian and pulmonary arteries of the type "end to side". |
Timeline
- Start date
- 2016-05-05
- Primary completion
- 2019-03-18
- Completion
- 2019-11-22
- First posted
- 2016-08-10
- Last updated
- 2020-06-30
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02861963. Inclusion in this directory is not an endorsement.